Cabaletta Bio (CABA) Receivables - Accured (2018)

Cabaletta Bio (CABA) posted quarterly Receivables - Accured of $409000.0 for Q4 2018.

Cabaletta Bio (CABA) Receivables - Accured (2018) Analysis & Trends

Cabaletta Bio's Receivables - Accured history runs 1 years deep, the most recent figure standing at $409000.0 for Q4 2018.

In Q4 2018, Receivables - Accured changed N/A year-over-year to $409000.0; the TTM figure through Dec 2018 stood at $409000.0 (changed N/A YoY), while the FY2018 annual figure was $409000.0, changed N/A from the prior year.
Receivables - Accured for Q4 2018 stood at $409000.0.
The five-year high for Receivables - Accured was $409000.0 in Q4 2018, with the low at $409000.0 in Q4 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acc. Int. Receivables (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Cabaletta Bio	466.25 Mn	466.25 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2018	409,000.00
Dec 31, 2018	409,000.00